The majority of COVID-19 patients in our study, with critical or severe disease (oxygenation impairment) showed no IL-24 concentrations above the LLOQ during their hospital stay, as determined from serial blood samples collected at time points H1–H5. Here, IL24 is linked to COVID-19.